Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 123

1.

Targeting of key pathogenic factors from gram-positive bacteria by the soluble ectodomain of the scavenger-like lymphocyte receptor CD6.

Martínez-Florensa M, Consuegra-Fernández M, Martínez VG, Cañadas O, Armiger-Borràs N, Bonet-Roselló L, Farrán A, Vila J, Casals C, Lozano F.

J Infect Dis. 2014 Apr 1;209(7):1077-86. doi: 10.1093/infdis/jit624. Epub 2013 Nov 21.

PMID:
24265437
2.

Pulmonary innate immune proteins and receptors that interact with gram-positive bacterial ligands.

Palaniyar N, Nadesalingam J, Reid KB.

Immunobiology. 2002 Sep;205(4-5):575-94. Review.

PMID:
12396017
3.

The cell wall components peptidoglycan and lipoteichoic acid from Staphylococcus aureus act in synergy to cause shock and multiple organ failure.

De Kimpe SJ, Kengatharan M, Thiemermann C, Vane JR.

Proc Natl Acad Sci U S A. 1995 Oct 24;92(22):10359-63.

4.

Gene expression profiling of bovine mammary gland epithelial cells stimulated with lipoteichoic acid plus peptidoglycan from Staphylococcus aureus.

Im J, Lee T, Jeon JH, Baik JE, Kim KW, Kang SS, Yun CH, Kim H, Han SH.

Int Immunopharmacol. 2014 Jul;21(1):231-40. doi: 10.1016/j.intimp.2014.05.002. Epub 2014 May 14.

PMID:
24836680
5.

Differential roles of TLR2 and TLR4 in recognition of gram-negative and gram-positive bacterial cell wall components.

Takeuchi O, Hoshino K, Kawai T, Sanjo H, Takada H, Ogawa T, Takeda K, Akira S.

Immunity. 1999 Oct;11(4):443-51.

6.

Gene expression profile of human peripheral blood mononuclear cells induced by Staphylococcus aureus lipoteichoic acid.

Kang SS, Kim HJ, Jang MS, Moon S, In Lee S, Jeon JH, Baik JE, Park OJ, Son YM, Kim GR, Joo D, Kim H, Han JY, Yun CH, Han SH.

Int Immunopharmacol. 2012 Aug;13(4):454-60. doi: 10.1016/j.intimp.2012.05.010. Epub 2012 May 29.

PMID:
22652070
7.
8.

Peptide mimics of peptidoglycan are vaccine candidates and protect mice from infection with Staphylococcus aureus.

Chen Y, Liu B, Yang D, Li X, Wen L, Zhu P, Fu N.

J Med Microbiol. 2011 Jul;60(Pt 7):995-1002. doi: 10.1099/jmm.0.028647-0. Epub 2011 Mar 24.

PMID:
21436375
10.

CD6 binds to pathogen-associated molecular patterns and protects from LPS-induced septic shock.

Sarrias MR, Farnós M, Mota R, Sánchez-Barbero F, Ibáñez A, Gimferrer I, Vera J, Fenutría R, Casals C, Yélamos J, Lozano F.

Proc Natl Acad Sci U S A. 2007 Jul 10;104(28):11724-9. Epub 2007 Jun 29.

11.

Lipoteichoic acid and peptidoglycan from Staphylococcus aureus synergistically induce neutrophil influx into the lungs of mice.

Leemans JC, Heikens M, van Kessel KP, Florquin S, van der Poll T.

Clin Diagn Lab Immunol. 2003 Sep;10(5):950-3.

13.
14.
15.

Inhibitory role for D-alanylation of wall teichoic acid in activation of insect Toll pathway by peptidoglycan of Staphylococcus aureus.

Tabuchi Y, Shiratsuchi A, Kurokawa K, Gong JH, Sekimizu K, Lee BL, Nakanishi Y.

J Immunol. 2010 Aug 15;185(4):2424-31. doi: 10.4049/jimmunol.1000625. Epub 2010 Jul 16.

16.

The selective guanylate cyclase inhibitor ODQ reduces multiple organ injury in rodent models of Gram-positive and Gram-negative shock.

Zacharowski K, Berkels R, Olbrich A, Chatterjee PK, Cuzzocrea S, Foster SJ, Thiemermann C.

Crit Care Med. 2001 Aug;29(8):1599-608.

PMID:
11505136
17.

Pathogenesis of septic shock: implications for prevention and treatment.

Calandra T.

J Chemother. 2001 Nov;13 Spec No 1(1):173-80. Review.

PMID:
11936363
18.
20.

Protective Effects of Human and Mouse Soluble Scavenger-Like CD6 Lymphocyte Receptor in a Lethal Model of Polymicrobial Sepsis.

Martínez-Florensa M, Consuegra-Fernández M, Aranda F, Armiger-Borràs N, Di Scala M, Carrasco E, Pachón J, Vila J, González-Aseguinolaza G, Lozano F.

Antimicrob Agents Chemother. 2016 Dec 27;61(1). pii: e01391-16. doi: 10.1128/AAC.01391-16. Print 2017 Jan.

PMID:
27895015

Supplemental Content

Support Center